Gabriel Fares

Ms. Gabriel Fares


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2025 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
FDFatima Dandash
Fatima Dandash
ZSZahraa Salhab
Zahraa Salhab
RIRawan Issa
Rawan Issa
ZDZeinab Al Dirani
Zeinab Al Dirani
MHMariam Hamze
Mariam Hamze
HFHUSSEIN FAYYAD-KAZAN
HUSSEIN FAYYAD-KAZAN

19 November 2025 in Viruses
Verified
Journal Article
Open access
PDF file
SASalman Ayman Almashtoub
Salman Ayman Almashtoub
Gabriel FaresGabriel Fares
Gabriel Fares
TATasnime Abdel Halim Abdo Ahmad
Tasnime Abdel Halim Abdo Ahmad
SBSara Barada
Sara Barada
ATAhmad Turk
Ahmad Turk
ESEsber Saba
Esber Saba
(1) Background: The emergence of multidrug-resistant (MDR) Salmonella enterica poses a major threat to global public health, underscoring the urgent need for alternative therapeutic strategies. Bacteriophages represent a promising alternative due to their high specificity and potent ability to lyse MDR strains. (2) Methods: In this study, we isolated a novel MDR Salmonella Enteritidis-targeting bacteriophage from Lebanese sewage and characterized its host range, thermal and pH stability, and infection dynamics. Whole-genome sequencing was performed using Illumina technology to determine its genetic features and taxonomic classification. (3) Results: the bacteriophage was classified within the genus Jerseyvirus and the class Caudoviricetes with a 43 kb dsDNA genome encoding 66 open reading frames (ORFs). It demonstrated remarkable thermal stability, retaining infectivity after prolonged incubation at 65 °C, and showed a broad host range. The phage formed large, clear plaques, displayed rapid adsorption (>97% within 3 min), a short latent period (20 min), and a burst size of ~32 PFU per cell. Genome analysis revealed no lysogeny, virulence, or resistance genes, confirming its strictly lytic nature and supporting its potential use as a biocontrol agent. (4) Conclusions: These findings identify SA01 as a novel, strictly lytic, and thermally stable bacteriophage with strong potential as a biocontrol agent against multidrug-resistant Salmonella Enteritidis. Its broad host range suggests potential activity also against other Salmonella enterica serovars, supporting its applicability in food safety and biotechnology.

17 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SASalman Ayman Almashtoub
Salman Ayman Almashtoub
Gabriel FaresGabriel Fares
Gabriel Fares
TATasnime Abdel Halim Abdo Ahmad
Tasnime Abdel Halim Abdo Ahmad
SBSara Barada
Sara Barada
ATAhmad Turk
Ahmad Turk
ESEsber Saba
Esber Saba
1) Background: The emergence of multidrug-resistant (MDR)-Salmonella enterica poses a major threat to global public health underscoring the urgent need for alternative therapeutic strategies where bacteriophages are a promising candidate due to their high specificity and potent ability to lyse MDR strains.2) Methods: In this study, we isolated a novel MDR-Salmonella Enteritidis-targeting bacteriophage from Lebanese sewage and characterized its host range, thermal and PH stability, and infection dynamics. Whole-genome sequencing was performed by Illumina to determine genetic features and taxonomic position.3) Results: the bacteriophage belongs to genus Jerseyvirus and Class Caudoviricetes with a 43kb dsDNA genome and 66 ORFs. It demonstrated extraordinary thermal stability, retaining infectivity after prolonged incubation at 65 °C, showed a broad host range, produced large, clear plaques, displayed rapid adsorption (>97% within 3 min), a short latent period (20 min), and a burst size of ~320 PFU per cell. Genome analysis revealed no lysogeny, virulence, or resistance genes, confirming its strictly lytic nature and supporting its potential use as a biocontrol agent. 4) Conclusions: These findings identify SA01 as a novel, strictly lytic, and thermally stable bacteriophage with strong potential as a biocontrol agent against multidrug-resistant Salmonella Enteritidis, supporting its potential activity also against other Salmonella enterica serovars for future applications in food safety and biotechnology.